Brian Bernick is Director at TherapeuticsMD, Inc. (TXMD). They have made 13 open-market trades across 1 company since 2013, most recently 2022-12-09.
CIK 0001532233
2 open-market purchases totalling $128K since 2019, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TXMD | 4,192 | $8K |
Shares reported on the most recent Form 4, priced at the 2022-12-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TXMD | SELL | 2022-12-06 | 2022-12-09 | $5.27 | $7K | -4.8% | -17.1% | -32.2% |
| TXMD | BUY | 2019-10-25 | 2019-10-29 | $2.75 | $99K | -3.4% | -14.9% | -14.9% |
| TXMD | BUY | 2019-08-09 | 2019-08-13 | $2.87 | $29K | -8.7% | +12.0% | -4.7% |
| TXMD | SELL | 2018-12-12 | 2018-12-14 | $4.14 | $1.1M | +2.6% | +30.6% | +45.1% |
| TXMD | SELL | 2018-11-30 | 2018-12-04 | $5.07 | $927K | -24.1% | -18.6% | +24.9% |
| TXMD | SELL | 2018-11-19 | 2018-11-21 | $4.75 | $867K | +0.6% | -23.7% | +24.3% |
| TXMD | SELL | 2018-11-08 | 2018-11-13 | $4.88 | $892K | +1.3% | -15.4% | +10.2% |
| TXMD | SELL | 2018-10-18 | 2018-10-22 | $5.58 | $1.5M | -5.2% | -6.5% | -1.9% |
| TXMD | SELL | 2018-10-04 | 2018-10-09 | $5.91 | $1.1M | -8.4% | -16.9% | -21.6% |
| TXMD | SELL | 2018-09-27 | 2018-10-01 | $6.59 | $1.2M | -5.7% | -17.5% | -35.8% |
| TXMD | SELL | 2018-09-12 | 2018-09-14 | $6.31 | $1.2M | +7.0% | -11.5% | -35.2% |
| TXMD | SELL | 2014-03-26 | 2014-03-27 | $6.70 | $2.8M | -26.4% | -1.1% | -1.1% |
| TXMD | SELL · 10b5-1 | 2014-02-11 | 2014-02-13 | $6.16 | $193K | -26.4% | -1.1% | -1.1% |
| TXMD | SELL · 10b5-1 | 2014-01-07 | 2014-01-08 | $5.13 | $160K | -26.4% | -1.1% | -1.1% |
| TXMD | SELL | 2013-08-26 | 2013-08-28 | $1.55 | $2.5M | -26.4% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.